Evidence map›Paper›PMID 37880302›Full record

ArticleScientific reports2023

Multifractal foundations of biomarker discovery for heart disease and stroke.

Madhur Mangalam, Arash Sadri, Junichiro Hayano, Eiichi Watanabe, Ken Kiyono, Damian G Kelty-Stephen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Madhur MangalamDivision of Biomechanics and Research Development, Department of Biomechanics, and Center for Research in Human Movement Variability, University of Nebraska at Omaha, Omaha, NE, 68182, USA. mmangalam@unomaha.edu.
Arash SadriLyceum Scientific Charity, Tehran, Iran.
Junichiro HayanoGraduate School of Medicine, Nagoya City University, Nagoya, Aichi, 467-8601, Japan.
Eiichi WatanabeDivision of Cardiology, Department of Internal Medicine, Fujita Health University Bantane Hospital, Nagoya, Aichi, 454-0012, Japan.
Ken KiyonoGraduate School of Engineering Science, Osaka University, Osaka, 560-8531, Japan.
Damian G Kelty-StephenDepartment of Psychology, State University of New York at New Paltz, New Paltz, NY, 12561, USA.
Fujita Health University Hospital · JPNagoya City University · JPOsaka University · JPSUNY New Paltz · USUniversity of Nebraska at Omaha · US

Funding

Visual control of locomotion in people with Parkinsons diseaseP20GM109090 · NIGMS · UNIVERSITY OF NEBRASKA OMAHA · PI MANGALAM, MADHUR · 2014 to 2023
$20.5M
NIGMS NIH HHS P20 GM109090NIGMS NIH HHS P20GM109090
6 · The paper itself

Abstract

Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-positive and false-negative rates. The application of standard cut-off points and risk scores across populations hinges upon the assumption of such generalizability. Such generalizability, in turn, hinges upon this condition that the phenomenon investigated by current statistical methods is ergodic, i.e., its statistical measures converge over individuals and time within the finite limit of observations. However, emerging evidence indicates that biological processes abound with nonergodicity, threatening this generalizability. Here, we present a solution for how to make generalizable inferences by deriving ergodic descriptions of nonergodic phenomena. For this aim, we proposed capturing the origin of ergodicity-breaking in many biological processes: cascade dynamics. To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and decades of research, lacks reliable biomarkers and risk stratification tools. We showed that raw R-R interval data and its common descriptors based on mean and variance are nonergodic and non-specific. On the other hand, the cascade-dynamical descriptors, the Hurst exponent encoding linear temporal correlations, and multifractal nonlinearity encoding nonlinear interactions across scales described the nonergodic heart rate variability more ergodically and were specific. This study inaugurates applying the critical concept of ergodicity in discovering and applying digital biomarkers of health and disease.

Indexed as

Heart DiseasesStrokeBiomarkersHeart RateHumansBiomarkers

Identifiers

PMID37880302
PMCPMC10600152
OpenAlexW4387934683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.